Abstract
Background
Familial adenomatous polyposis is a genetic syndrome associated with an increased risk of colorectal cancer (CRC) and different extracolonic manifestations.
Goals
The goal of this study is to evaluate the frequency of death causes.
Material and Methods
Charts from 97 patients treated from 1977 to 2008 were reviewed. Retrieved data and family information allowed us to classify causes of death in those related to CCR to other malignancies or other causes.
Results
There were analyzed data from 46 men (47.4%) and 51 women (52.6%) with an average age of 35.1 years (14 to 82). At diagnosis, 57 patients (58.7%) already had CRC-associated polyposis. There were performed 93 colectomies, one internal diversion, and one partial resection. Two patients were not operated on. Results from 19 deceased patients (19.5%) were analyzed. CRC, other tumors (desmoid tumors, lymphoma, and gastric cancer), and other causes (complication of duodenal cancer surgery, complication after ileorectal anastomosis (IRA), and coronary disease) were responsible for 12 (63.1%), four (21.1%), and three (15.8%) of all deaths, respectively. Death from CRC occurred in the context of either systemic, rectal, or pouch recurrence. Desmoid disease was the second cause of death (10.5% of all causes), leading to a fatal outcome 22% of all patients who developed DT during the study period. Upper digestive carcinomas were responsible for other two death cases.
Conclusions
(1) CRC is still the most prevalent cause of death; (2) even after curative resections, CRC can cause death through rectal or pouch malignization; (3) long-term survival was also strongly related to the development of extracolonic neoplasia, especially desmoid tumors and gastroduodenal carcinoma; (4) our results raise the need for local improvement in familiar screening and help us to define follow-up strategies and patient-information standards.
Similar content being viewed by others
References
Debinski HS, Love S, Spigelman AD, Phillips RK. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996; 110:1028-1030.
Arvanitis ML, Jagelman DG, Fazio VN, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33:639-642.
Belchetz LA, Berk T, Bapat BV, Cohen Z, Gallinger S. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996; 39:384-387
Lockhart-Mummery P. Cancer and heredity. Lancet 1925; 1:427-429.
Galle TS, Juel K, Bülow S. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999; 34:808-812.
Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer registries in the United States. Dis Colon Rectum. 2004; 47(5): 674-8.
Gardner EJ. A genetic and clinical study of intestinal polyposis: a predisposing factor for carcinoma of the colon and rectum. Am J Genet 1951; 3: 167 – 76.
Crail HW .Multiple primary malignancies arising in the rectum, brains and tyroid: report of a case. US Naval Med Bull 1949; 49: 123
Bertario L, Presciuttini S, Sala P, Rossetti C, Pietroiusti M. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. Semin Surg Oncol 1994;10(3):225-34.
Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg. 1993; 217(2):101-8.
Groen EJ, Roos A, Muntinghe FL, Enting RH, Vries J, Kleibeuker JH, Witjes MJH, Links TP, van Beek AP. Extra-Intestinal Manifestations of Familial Adenomatous Polyposis . Ann Surg Oncol. 2008; 15(9): 2439–2450.
Campos FG, Habr-Gama A, Kiss DR, Atui FC, Katayama F, Gama-Rodrigues J. Extracolonic manifestations of familial adenomatous polyposis: incidence and impact on the disease outcome. Arq Gastroenterol. 2003; 40(2): 92-8.
Tulchinsky H, Keidar A, Strul H, Goldman G, Klausner JM, Rabau M. Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy. Arch Surg 2005; 140: 159-63.
Bulow S. Results of national registration of familial adenomatous polyposis. Gut. 2003; 52:742-746.
Vasen HF, Griffioen G, Offerhaus GJ, Den Hartog Jager FC, Van Leeuwen-Cornelisse IS, Meera Khan P, Lamers CB, Van Slooten EA. The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands. Dis Colon Rectum. 1990; 33(3): 227-30.
Heiskanen I. Clinical studies on Familial Adenomatous Polyposis. Academic Dissertation from the Medical Faculty of the University of Helsinki, 2000. Available in https://oa.doria.fi/dspace/bitstream/10024/2015/1/clinical.pdf.
Järvinen H J. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut. 1992; 33(3): 357–360.
Campos FG, Imperiale AR, Seid VE, Perez RO, da Silva e Sousa AH Jr, Kiss DR, Habr-Gama A, Cecconello I. Rectal and pouch recurrences after surgical treatment for familial adenomatous polyposis. J Gastrointest Surg. 2009; 13(1):129-36.
Campos FG, Habr-Gama A, Kiss DR, da Silva EV, Rawet V, Imperiale AR, Perez R, da Silva JH, Sousa AH Jr, Gama-Rodrigues J. Adenocarcinoma after ileoanal anastomosis for familial adenomatous polyposis: review of risk factors and current surveillance apropos of a case. J Gastrointest Surg. 2005; 9(5):695-702.
Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for Familial Adenomatous Polyposis. Dis Colon Rectum. 1993; 36(11):1059-62.
P1arc Y, Piquard A, Dozois RR, Parc R, Tiret E. Long term outcome of familial adenomatosis polyposis patients after restorative coloproctectomy. Ann Surg. 2004; 239:378-382.
Remzi FH, Church JM, Bast J, Lavery IC, Strong SA, Hull TL, Harris GJ, Delaney CP, O'Riordain MG, McGannon EA, Fazio VW. Mucosectomy vs. stapled ileal pouch-anal anastomosis in patients with familial adenomatous polyposis: functional outcome and neoplasia control. Dis Colon Rectum 2001; 44(11):1590-6.
King JE, Dozois RR, Lindor NM, Ahlquist DA. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc. 2000; 75:57-67.
Croner RS, Brueckl WM, Reingruber B, Hohenberger W, Guenther K. Age and manifestation related symptoms in familial adenomatous polyposis. BMC Cancer 2005; 5(1):24
Iwama T, Tamura K, Morita T, Hirai T, Hasegawa H, Koizumi K, Shirouzu K, Sugihara K, Yamamura T, Muto T, Utsunomiya J. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol. 2004; 9 (4): 308-16.
Heiskanen I, Järvinen HJ. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis. 1996;11(4):157-62.
Hartley JE, Church JM, Gupta S, McGannon E, Fazio VW. Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum. 2004; 47(3): 334-8.
Duggal A, Dickinson IC, Sommerville S, Gallie P. The management of extra-abdominal desmoid tumours. Int Orthop. 2004; 28: 252-6.
Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg. 1999; 86(9):1185-9.
Church J, Lynch C, Neary P, LaGuardia L, Elayi E. A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum 2008; 51(6):897-901.
Burt RW. Gastric fundic gland polyps. Gastroenterology 2003; 125:1462-9.
Offerhaus GJ, Entius MM, Giardiello FM. Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 1999; 46: 667-9.
Heiskanen I, Kellokumpu I, Järvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy. 1999; 31(6):412-6.
Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlström J, Martinsson T, Nordling M, Hultcrantz R. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations.Gastroenterology. 2001; 121(5):1127-35.
Bülow S, Björk J, Christensen IJ, Fausa O, Järvinen H, Moesgaard F, Vasen HF; DAF Study Group. Duodenal adenomatosis in familial adenomatous polyposis. Gut. 2004; 53(3):381-6.
Vasen HF et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57:704-713.
Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001; 16: 63–75.
Mackey R, Walsh RM, Chung R, Brown N, Smith A, Church J, Burke C. Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis. J Gastrointest Surg 2005; 9: 1088-93.
Nugent KP, Spigelman AD, Phillips RK. Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg. 1996;83(8):1121-2.
Author information
Authors and Affiliations
Corresponding author
Additional information
Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, and Cecconello I. Evaluating causes of death in Familial Adenomatous Polyposis.
Rights and permissions
About this article
Cite this article
de Campos, F.G.C.M., Perez, R.O., Imperiale, A.R. et al. Evaluating Causes of Death in Familial Adenomatous Polyposis. J Gastrointest Surg 14, 1943–1949 (2010). https://doi.org/10.1007/s11605-010-1288-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-010-1288-6